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Ciproﬂoxacin (CIP), tamoxifen (TAM) and cyclophosphamide (CP) which are often used in anticancer treatment
are released in hospital efﬂuent and into the environment. Although the concentrations are low (from ng/L to
μg/L), no data exist concerning their ecotoxicological impact. In this study two biomarkers of early effect were
performed on hepatic cells (HepG2): cell viability and genotoxicity (DNA breaks) using cell proliferative assay
and comet assay, respectively. These datawere comparedwith two standardized ecotoxicological tests: algaltoxkit
F™ andmicrotox®. Cells were exposed to an increasing amount of an individual drug or in a mixture for 24, 48 or
72 h. The time-exposure of bacteria and algae ranged between 5 and 30 min and 72 h, respectively. A
non-monotonic dose–response on cell viability was observed when HepG2 cells were exposed to TAM alone or
in the presence of CIP. The same scheme was observed with microtox® when the bacteria were exposed to the
mixtures. On the other side, an individual drug doesnot induce anyDNAbreakson hepatic cells,whereas amixture
leads to a dose dependent increase of DNA breaks. Similarly a positive response was observed with algaltoxkit F™
only with mixtures. Synergistic effects observed when drugs are in a mixture highlight the importance of
investigating the ecotoxicological effects of contaminants at low concentrations and in mixtures.
1. Introduction
All over the world, the number of cancers is in constant progression
leading to a dramatic increase of treatments. These treatments are
chemotherapy and radiotherapy which can be used combined or not.
Chemotherapy is realized by means of anticancer drugs having toxic
properties for cells, and of which most are classiﬁed in three categories
by the International Agency for Research on Cancer (IARC): carcinogenic
impact for humans (class 1); likely carcinogenic (class 2); andpotentially
carcinogenic (class 2B). Cytostatic drugs act on cell growth inhibition or
directly kill cells but in an unselective way on both tumoral and healthy
cells. Therefore, many antineoplastic agents have cytotoxic, mutagenic,
carcinogenic, embryotoxic and/or teratogenic effects. During the
treatments, these drugs are eliminated in large proportion under parent
compounds or metabolite forms via the urine and feces of patients.
Hospital efﬂuents which are generally released directly to the sewage
networkwithout pretreatment represent an incontestable release source
of many bioactive substances used for medical and research purposes
such as pharmaceuticals, radioisotopes or solvents (Emmanuel et al.,
2005; Verlicchi et al., 2012). Although many of these compounds are
removed by adsorption (Carabineiro et al., 2011) or biodegradation in
wastewater treatment plants (WWTP), some molecules are directly re-
leased into the environment (Besse et al., 2012; Gartiser et al., 1996;
Halling-Sørensen et al., 1998; Kuemmerer et al., 1997)where they repre-
sent a potential toxic hazard for ecosystems and human health via drink-
ing water (Johnson et al., 2008; Rowney et al., 2009; Zegura et al., 2009).
Cytostatic agents are mainly found in hospital wastewater, and their use
increases by 10% each year. WWTPs can eliminate some cytostatic
agents, but the removal rate is not equal between molecules (e.g. 25%
for cyclophosphamide and 75% for methotrexate) (Catastini et al.,
2010). Concentrations of contaminants in potable water are usually in
the range from subnanogram/L to μg/L, which is generally below the
detection limit of biological assays (Besse et al., 2012). Nevertheless
many of them or their metabolites raise considerable toxicological con-
cerns particularly when present as components of complex mixtures
(Hernando et al., 2006; Zegura et al., 2009). For example, some endocrine
active drugs possess an extremely high biological potency down to the
μg/day; therefore it is very likely that they also cause effects at very
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low concentrations in the environment. Thus, the contraceptive
17β-ethinylestradiol adversely affects the reproduction of zebraﬁsh
(Danio rerio) at concentrations as low as 1 ng/L (Wenzel et al., 2001).
Data reported by Coe et al. (2008) suggest that exposure to some estro-
gens at low ng/L concentrations detected in recipient water bodies can
even deteriorate the reproductive behavior by alternating mating habits.
The risk posed by cytostatic molecules and by mixtures is still not
well documented and it is not possible to conclude on their long-term
effects on non-target organisms. Until today, ecotoxicological effects
have been assessed by standardized tests or by non speciﬁc in vitro as-
says. Such a test however may not suitable for anticancer drugs
(Zounkova et al., 2010). Tools to characterize the drug removal process
efﬁciency and to assess the impact of these pollutants on aquatic life and
human health must be further developed and reﬁned.
The aim of this paper was to compare potential biomarkers sensitive
enough for toxic evaluation of lowdoses of drugs found in hospital efﬂu-
ents, river or drinking water. We selected three compounds (ciproﬂox-
acin (CIP), cyclophosphamide (CP), tamoxifen (TAM), Fig. 1) frequently
used in cancer treatment and found at lowdoses in hospitalwastewater,
municipal wastewater treatment plants (WWTPs) and surface water
(Hartmann et al., 1998; Thomas and Hilton, 2004; Zuccato et al.,
2005). Cyclophosphamide (CP) is primarily used as an anticancer
chemotherapeutic but is also used as an immunosuppressive agent in
several treatments of arthritis, interstitial pneumonia, etc. or during
organ transplantation. Tamoxifen (TAM) is a selective estrogen receptor
modulator used in breast cancer treatment, which acts as an antagonist
competitor in theα-ER1 estrogen receptor (mammary tissues) and like
an agonist competitor in cholesterol metabolism (Coezy et al., 1982;
Jordan and Koerner, 1975). TAM belongs to compounds put on the pri-
oritization list, due to the potential of this substance to bioaccumulate in
the human body and probably in aquatic organisms (Jean et al., 2012).
In ﬁsh, dose-dependent effects have been reported on the rate of
vitellogenin synthesized in males and on sex-ratio disturbance of the
population (also dose-dependent) whose parents were exposed to
concentrations of tamoxifen higher than 5 μg/L (Liwei et al., 2007).
Ciproﬂoxacin (CIP), which belongs to the ﬂuoroquinolone class, is an
antibiotic that inhibits the enzyme activity necessary for replication,
transcription, repair and recombination of bacterial DNA (McLellan
et al., 1996). This drug is often used against the side effects of treatment
protocols, particularly in fever prevention and infections arising after
chemotherapy of breast cancer, cancer of the ovaries or the small cell
lung cancer (SCLC) (Tjan-Heijnen et al., 2001).
The three drugs can be found inwastewater in the range of 10 ng/L to
10 μg/L for TAM and CP, and 10 ng/L to 100 μg/L for CIP (Lindberg et al.,
2004, 2005; Roberts and Thomas, 2006; Thomas andHilton, 2004; Zorita
et al., 2009; Zuccato et al., 2005). As CIP is widely used for therapeutic
treatments it is 10-fold more concentrated in hospital efﬂuents and 2-
fold more concentrated in municipal WWTP efﬂuents than TAM and
CP. Among the ﬂuoroquinolones, ciproﬂoxacin (CIP) was the most fre-
quently detected in wastewater and surface waters with concentrations
of several hundred ng/L (Karthikeyan and Meyer, 2006; Kolpin et al.,
2002; Miao et al., 2004). Higher concentrations up to 150 μg/L were
even reported in the efﬂuents from hospitals (Martins et al., 2008).
The application of bioassays is an important approach for investigat-
ing the causal relationship between exposure to environmental pollut-
ants and the effects on individuals and populations. For example,
somemicroalgae are known to be highly sensitive to the contamination
of aquatic environments (Eguchi et al., 2004). Algae play an important
role in the equilibrium of aquatic systems where they are involved in
nutrient cycling and O2 production. They therefore form the base of
many aquatic food chains; consequently, death of algae will impact
aquatic life. They are considered indicators of bioactivity, such as indus-
trial waste, and vary in response to a variety of toxicants (Ma et al.,
2006) and reﬂect chronic aquatic toxicity. On the other handMicrotox®
reﬂects acute aquatic toxicity.
The use of a battery of bioassays in ﬁeld monitoring has been increas-
ing over the past 15 years (Orias and Perrodin, 2013). Genotoxicity
biomarkers are now considered to be an integral part of this approach
because exposure to genotoxic agents may exert damage beyond that of
individuals and may be detected through several generations (Frenzilli
et al., 2009). The Comet assay has already been included in the strategy
guidelines for the testing of chemical mutagenicity (EFSA, 2012). The
Comet assay was chosen as an indicator test for its sensitivity to detect
small amounts of DNA damage, for being ﬂexible and for requiring only
small numbers of cells (Tice et al., 2000). Especially the alkaline Comet
assay with sperm – a relatively new technique –may become important,
as it is very sensitive in assessing genotoxic damage (Baumgartner et al.,
2007). The in vitro evaluation of DNA damage on cells will help establish
feasible, adequate and expedient biomarkers of exposure.
For this reason to be close to the real contamination levels found in
waste water, human hepatoma cell line HepG2 has been exposed to
the drugs in a range of concentrations from 1 ng/L to 100 μg/L. HepG2
cells have been chosen because they are extensively used for toxicity
and genotoxicity evaluation of pure compounds and retained many
of the properties of primary liver cells, including the metabolic acti-
vation (Lu and Huang, 1994). Owing to their endogenous expression
of a variety of xenobiotic metabolizing enzymes, this cell lines are
useful for detecting the combined effects of chemicals in a mixture
(Mersch-Sundermann et al., 2004; Zegura et al., 2009). Furthermore,
it has been widely described that zearalenone (a phytoestrogen) and
its metabolites competitively bind to estrogen receptors in different
cell models including HepG2 cells (Breithofer et al., 1998). Both
viability and genotoxicity revealed by comet assay were evaluated
on cells and a comparison was made with two standard tests:
microtox® and algaltoxkit F™.
2. Materials and methods
2.1. Chemicals
Ciproﬂoxacin (CIP), tamoxifen citrate (TAM), cyclophosphamide
(CP) and agarose were obtained from Sigma-Aldrich (France). Cell cul-
ture reagents including fetal calf serum and material were obtained
from Fisher Scientiﬁc (France). The 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt
Fig. 1. Chemical structure of ciproﬂoxacin [CIP] (A), tamoxifen [TAM] (B) and cyclophosphamide [CP] (C).
(MTS) was obtained from Promega (France). All solutions were pre-
pared using ultrapure water.
2.2. Cell culture
The HepG2 cell line (American Type Culture Collection, HB-8065)
was cultured in 75-cm2 polystyrene ﬂasks with minimum essential
medium supplemented with 10% heat-inactive fetal bovine serum,
10% L-glutamine (200 mM), 1% penicillin (100 U/mL), 1% streptomycin
(100 mg/mL), and 1 mM sodium pyruvate under an atmosphere of 5%
CO2 at 37 °C. Viable cell count was assessed by Trypan Blue exclusion
before toxic evaluation.
2.3. Cell, algae and bacteria treatments
Ciproﬂoxacin (CIP), tamoxifen citrate (TAM) and cyclophosphamide
(CP)) were dissolved in HCl, methanol and water respectively for stock
solution and stored at−20 °C. Prior to the treatments, the compounds
were diluted in the culture medium in order to give a ﬁnal solvent
concentration below 0.1%. None of these solvents at this dose affected
cell viability, bacteria viability, and algae growth.
Hepatic cells (HepG2), algae and bacteria were exposed to increas-
ing concentrations of the respective drugs (CIP, TAM, CP), or to a binary
mixture of CIP + TAM or to a mixture of the 3 drugs (CTC) in the range
of concentrations found in water as described in Table 1. Conditions 1
and 2 represent low doses close to environmental concentrations (sur-
face water), condition 3 close to WWTP concentrations with a 2-fold
factor of CIP, and conditions 4 and 5 represent hospital wastewater
concentrations with a 10-fold factor of CIP. In condition 0 cells received
only medium. This latter condition corresponds to control.
2.4. MTS cell proliferation assay
The assay was performed in accordance with themethod by Barltrop
et al. (1991). In brief, cell metabolic activity was determined bymonitor-
ing themitochondrial dependent reduction of 3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
inner salt (MTS) using a commercial assay (CellTiter 96 AQueous,
Promega). Subcultures for experimentswere prepared the day preceding
in 96-multiwell plates at a density of 5.5 × 103 cells/well and 18 h after
plating, the medium was discarded and fresh medium containing drugs
individually or inmixtures as described in Table 1 at different concentra-
tions was added. Cells were exposed to drugs during 24 to 72 h then
20 μL of the MTS reagent was added to each well and incubated for 2 h
at 37 °C, 5% CO2. The reduction of MTS was monitored by recording the
change in absorbance (A) at 490 nm using the automated Dynex plate
reader. The amount of reduced MTS was calculated as a percentage of
the absorbance determined by comparison with the standard condition.
Percentsurvivingcells ¼ Atest sample=Acontrol sample
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2.5. Alkaline single cell gel electrophoresis (SCGE) assay
2.5.1. Treatment
Subcultures for experiments were prepared the day preceeding the
test. HepG2 cells were plated onto 12-multiwell plates at a density of
1 × 105 cells/well and allowed to attach overnight. The medium was
then discarded and replaced by 2 mL of test medium and treated cells
and control cells were incubated for 24 h to 72 h.
2.5.2. Slide preparation
The comet assay was performed according to Singh et al. (1988)
with minor modiﬁcations. All the procedures were conducted in the
dark and on ice to minimize spurious sources that might cause DNA
damage. Conventional microscope slides were dipped in 1.6% agarose
and allowed to dry on a ﬂat surface at room temperature before the
experiment. The ﬁrst layer with a 0.8% normal melting point (NMP) in
PBS (phosphate saline buffer containing NaCl 137 mM, KCl 2.7 mM,
Na2HPO4 4.3 mM, KH2PO4 1.47 mM, pH 7.4) kept at 37 °C was added
onto frosted slides and gently covered with a cover-slide. The cell pellet
obtained by centrifugation for 5 min at 4 °C, 4000 rpm,was resuspend-
ed in 150 μL to a ﬁnal cell-agarose solution containing approximately
5 × 104 cells in 0.5% low melting point (LMP) agarose in PBS and
75 μL was added as the second layer onto duplicate slides. The third
layer (75 μL 0.5% LMP agarose) was added and the slides were placed
in fresh lysis solution (2.5 M NaCl, 100 mM EDTA-Na2, 10 mM Tris,
pH 10; 1% Triton X-100, 10% DMSO, pH 10) at 4 °C for 1 h. The slides
were transferred on a horizontal electrophoresis tray and submerged
in denaturation buffer (1 mM EDTA, 300 mM NaOH, pH 13) for
20 min. Electrophoresis was carried out using the same solution for
20 min at 26 V and 350 mA (0.8 V/cm) then the slides were gently
washed three times for 5 min in a cold neutralizing buffer (400 mM
Tris, pH 7.4). Slides were dried in methanol and stored in a low humid-
ity environment until analysis.
2.5.3. Slide analysis
Fewminutes before analysis, 50 μL of ethidium bromide (40 μg/mL)
was dropped onto the agarose and covered with a coverslip. Fifty cells
per slidewere randomly scored at 250×magniﬁcationwith anOlympus
BX50 ﬂuorescence microscope equipped with an excitation ﬁlter of
515–560 nmand a barrierﬁlter of 590 nm. DNA damagewas quantiﬁed
by tail DNA and median values were calculated by a Komet 5.5 image
analysis system (ANDOR Technology, Belfast, UK).
Positive control was run using ethyl-methanesulfonate (EMS).
2.6. Algaltoxkit F™ assay: Selenastrum capricornutum
The growth inhibition of green algae S. capricornutumbioassays from
MicroBioTests Inc. (Gent, Belgium) was performed following the
standard operational procedures of algaltoxkit F™ (1996). This test
was conducted in accordance with OECD Guideline 201 (2002). Tests
were carried out with S. capricornutum obtained from the Culture
Collection of Algae and Protozoa (CCAP), Argyll, Scotland. Allmicroalgae
growth inhibition tests were conducted at 25 °C with continuous
illumination of 10,000 lx.
The algaltoxkit technology is based on the (rapid) measurement of
the optical density (OD) of 25 mL algal cell suspensions in disposable
spectrophotometric cells of 10 cm path length, called “long cells”.
Negative controls were incorporated for each test containing only
algal growth media and algal inoculum. The initial algal density was
1 × 104 cells/mL and the density of each replicate was measured at
670 nm after 72 h using a spectrophotometer. Average of speciﬁc
growth and percentage of inhibition for each concentration were calcu-
lated by comparison with standard condition. Test validity criteria
required algal growth in control ﬂasks to increase by a factor of 16with-
in the 72 h test period and pH not to have varied bymore than 1.5 units
relative to the initial pH in the growth medium. The reference chemical
Table 1
Nominal concentrations of drugs used for treatments.
Unit Code conditions
0 1 2 3 4 5
Drugs (individually)
CIP μg/L 0 0.01 0.1 1 10 100
TAM μg/L 0 0.01 0.1 0.5 1 10
CP μg/L 0 0.01 0.1 0.5 1 10
Drugs (in mixture)
CIP μg/L 0 0.01 0.1 1 10 100
TAM μg/L 0 0.01 0.1 0.5 1 10
CIP μg/L 0 0.01 0.1 1 10 100
TAM μg/L 0 0.01 0.1 0.5 1 10
CP μg/L 0 0.01 0.1 0.5 1 10
potassium dichromate (K2Cr2O7) was employed as a positive control to
ensure the validity of the test method.
2.7. Microtox® assay: Vibrio ﬁscheri
Microtox® Reagent (V. ﬁscheri NRRL-B 11177) from AZUR Environ-
mental (Carlsbad, CA, USA) was reconstituted and bacteria were
cultured, harvested and frozen in cryoprotectant. Bioluminescence
inhibition was evaluated using the basic test protocol and was
determined at 5-, 15-, and 30-min intervals (Azur Environmental,
1998). The thawed bacterial suspension was used for the toxicity tests.
The number of viable bacteria in the photobacterial luminescence inhi-
bition tests was ~106 bacteria per mL of test solution, and the toxicity
testing was performed at 15 °C. The measurements were made by
using a 1253 Luminometer (Labsystems, Helsinki, Finland) connected
to a personal computer and the calculation of inhibitory % was
performed by means of standard software (Labsystems, Helsinki,
Finland). A basic test was also conducted with the reference standard
phenol for each fresh vial of bacteria opened to ensure the validity of
the test method.
2.8. Statistical analysis
All experiments were independently performed three times under
the same conditions and results were calculated in median values
with standard deviation (SD). As the distribution of cell viability and
SCGE assays deviated fromnormality, data following the Kruskal–Wallis
test, a non-parametric analog of the Dunnett's procedure for multiple
comparisons was used. Values were considered signiﬁcant (*) at
p b 0.05 and (**) at p b 0.01.
The statistical signiﬁcance of values from standardized bioassays
(microtox®; algaltoxkit F™) was checked using a one-way analysis of
variance ANOVA test using Statistica 9.0 package software. Post-hoc
comparisons between control and samples were made using Fisher's
test to determine which values signiﬁcantly differed at p b 0.05 (*).
2.9. Interaction analysis
To address the interaction of binary (CIP + TAM) or ternary
mixtures (CIP + TAM + CP) the effects were compared to the expect-
ed effects that were calculated from single compound toxicity obtained
in the same experiments. The two reference model of concentration
addition (CA) and the independent action (IA) were used to derive
patterns of joint effects of mixture (Chou, 2006, 2011). If the interaction
is strictly additive [1 − E(Ca)] × [1 − E(Cb)] = 1 − E(Cmix), where
E(Ca) is the effect induced by the compound a alone; E(Cb) the effect in-
duced by the compound b alone and E(C mix) is the effect observed
when the compounds are mixed. In other word if the ratio expected
value (E)/observed value (O) = 1 the interaction is strictly additive, if
ratio N1, the interaction is synergistic andwhen the ratio b1 the interac-
tion is antagonistic.
3. Results
3.1. HepG2 cell viability
Viability of HepG2 cells after exposure to drugs alone or mixed was
detected by the MTS cell proliferation assay. The data (Figs. 2 and 3)
are expressed as percentage of viable cells compared to non-exposed
cells. Each value corresponds to the median value of 15 measurements
(3 experiments, ﬁve replicates). Whatever the exposure time of hepatic
cells to CP, a slight but signiﬁcant (p b 0.05) decrease of cell viability
was only observed with the highest dose tested (10 μg/L) (Fig. 2A and
B). Exposure of cells to the lowest concentration (10 ng/L) of CIP or
TAM signiﬁcantly (p b 0.01) reduced cell viability (Fig. 2A) and the inhi-
bitionwas timedependent (Fig. 2B).With higher doses of CIP (100 ng/L–
10 μg/L), the cytotoxicity is lower than with 10 ng/L and was not
dose dependent. Exposure to a ten-fold higher concentration of CIP
(100 μg/L), signiﬁcantly (p b 0.01) decreases the cell viability. The
percentages of viable cells exposed to 100 μg/L of CIP were 90% and
80% respectively after 24 and 72 h of exposure. When cells are exposed
to TAM whatever the time of exposure a U-shaped dose–response
curve was observed.
Fig. 3 shows the combined effects of CIP + TAMor of the three drugs
(CTC) on HepG2 cell viability. The concentrations of exposure are de-
scribed in Table 1 (cf. Section 2.3). Whatever the length of cell exposure
to CIP + TAM a U-shaped dose–response curve was observed.
The inhibition of cell growth is lower than expected if a strictly
additive effect will occur (Table 2). When CP was added in the mixture
the antagonistic effect was higher compared to a binary mixture, with
almost no more impact on cell viability. Whatever the relative concen-
trations, the type of mixture (binary or ternary mixture) and the time
of exposure, the E/O ratio was always b1 indicating that an antagonistic
effect occurswhen thedrug are present together, even at very lowdoses
(Table 2). The antagonism is higher in the presence of CP compared to
CIP + TAM (Fig. 4).
3.2. DNA damage on HepG2 cells
The genotoxic effect of the three drugs on HepG2 was tested by
analysis of DNA single strand break formation using the comet assay.
In the range of concentrations tested (10 ng/L–10 μg/L) exposure of
cells to individual compounds did not induce anyDNAdamage,whatev-
er the exposure time (Fig. 5). Even exposure of cells to 10 more CIP
concentration did not induce any DNA breaks.
Simultaneous exposure to increasing concentrations of the three
drugs,whatever the time of exposure, signiﬁcantly increased DNAdam-
ages (Fig. 6). DNA breaks are two folds higher when cells are exposed to
10 μg/L of CP + 10 μg/L TAM + 100 μg/L CIP compared to 10 μg/L
TAM + 100 μg/L CIP (condition 5; Fig. 5A). The increase of DNAdamage
was dose dependent when the three drugs are present simultaneously
(Fig. 6) and was signiﬁcantly higher compared to exposure to binary
mixture. Although DNA breaks decreased with the time of exposure,
Fig. 2. Survival rate of HepG2 cells exposed to CP (▲); CiP) (–); TAM) (♦); during 24 h (A) to 72 h (B). Results are expressed as median value ± SD of the percentage of viable cells com-
pared to control condition. Statistically signiﬁcant at p b 0.05 (*) and p b 0.01 (**) compared to control cell.
even after 72 h, the amount of DNA damages observed when the cells
are exposed to the three drugs is signiﬁcantly higher (p b 0.01) com-
pared to treatment with CIP + TAM (Fig. 6B) and compared to control.
3.3. Growth inhibition of microalgae S. capricornutum
TAM signiﬁcantly (p b 0.05) stimulated the growth of microalgae
(Fig. 7). CIP has no effect on microalgae. The dose effect induced by CP
exhibited a U-shape form. With the lowest dose a slight but signiﬁcant
inhibition of algae growth was observed (p b 0.05); the highest CP
dose tested induced a proliferation.
Whenmicroalgaewere exposed to themixture (CIP + TAMor CTC)
whatever the exposure time, the algae growth was dose-dependently
inhibited (Fig. 8). There is no difference between exposure to binary
mixture (CIP + TAM) compared to mixture of the three drugs.
3.4. Extinction of bioluminescence of bacteria V. ﬁscheri
Except with CIP at the highest dose (100 μg/L), none of these drugs
inhibited V. ﬁscheri bioluminescence (Fig. 9).
In contrast, exposure of bacteria to the mixture induced a non-
monotone dose–response (U-shape curve), mainly with CIP + TAM
(Fig. 10). The addition of CP in themixture induced an antagonist effect.
For the lowest doses in the mixture, the inhibition of bacteria biolumi-
nescence was much higher when the three drugs were present com-
pared to only CIP + TAM. For the other conditions, the inhibitions
were lower in the presence of the three drugs compared to CIP + TAM
(Fig. 10).
4. Discussion
Recent studies show that among many environmental contami-
nants, pharmaceutical and personal care product (PPCP) residues in
the environment are of emerging concern. Cytostatic drugs and
human metabolites are directly discharged into the sewage system
without any speciﬁc control after being administered in the hospitals.
Household discharge by out-patients presents another pathway of cyto-
statics to the environment (Bound and Voulvoulis, 2006). Due to their
highly potent mechanism of action (cytotoxicity, genotoxicity, mutage-
nicity and teratogenicity), cytostatic drugs could induce adverse effects
on any growing eukaryotic organism and bacteria (Besse et al., 2012;
Johnson et al., 2008). Another point is also the deleterious effects of
these drugs for the hospital staff (Bouraoui et al., 2011; Burgaz et al.,
1999, 2002; Fucic et al., 1998).
In fact, some cytostatics have been detected in hospital wastewaters
and even inﬂuent wastewaters at concentrations ranging from ng/L to
μg/L (Buerge et al., 2006; Johnson et al., 2008; Negreira et al., 2013a,
2013b; Rowney et al., 2009). Although environmental concentrations
are below human therapeutic doses, the persistent release of these
drugs may lead to chronic effects at low concentration.
Massﬂuxes alone are insufﬁcient to evaluate the risk stemming from
pharmaceuticals; their ecotoxic potential needs to be considered.
Despite recent large efforts to increase the database on ecotoxicological
effects of pharmaceuticals (PhACT Database, 2006), the implications of
chronic low dose exposure of aquatic fauna and humans to environ-
mental discharge of these drugs remain largely unknown (Crane et al.,
2006). The lack of chronic toxicity data for drugs hinders the ability to
predict effects. In addition, using only physico-chemical analysis, it is
impossible to predict the toxic and/or genotoxic properties of complex
Fig. 3. Survival rate of HepG2 cells exposed to CIP + TAM ( ); CTC (x); during 24 h (A) to 72 h (B). The numbers 0–5 refer to themixture condition described in theM &Mpart (Table 1).
Results are expressed as median value ± SD of the percentage of viable cells compared to control (condition 0). Statistically signiﬁcant at p b 0.05 (*) and p b 0.01 (**) compared to
control cell.
Table 2
Comparison between expected additive values and results obtained in percentage (%) from HepG2 cell exposed during 24 h (A) and 72 h (B) to CIP + TAM and CTC. E/O is the ratio
between expected values (E) compared to observed values (O).
Drugs (in mixture) Condition
1 2 3 4 5
A.
CIP + TAM 91.52 ± 2.39 94.64 ± 1.51 93.97 ± 0.96 91.67 ± 1.09 90.23 ± 0.80
CIP + TAMexp. 85.71 90.88 90.35 88.34 83.43
E/O 0.94 0.96 0.96 0.96 0.92
CTC 98.57 ± 1.42 99.34 ± 1.10 98.44 ± 0.73 97.28 ± 1.21 94.52 ± 0.87
CTCexp. 84.04 90.91 89.84 87.14 80.94
E/O 0.85 0.92 0.91 0.90 0.86
B.
CIP + TAM 83.93 ± 0.11 89.22 ± 0.15 91.29 ± 0.38 91.03 ± 1.77 82.51 ± 0.18
CIP + TAMexp. 67.34 78.92 82.51 83.19 69.24
E/O 0.780 0.88 0.90 0.91 0.81
CTC 95.33 ± 1.46 99.72 ± 0.07 98.87 ± 0.78 98.24 ± 0.82 95.36 ± 1.54
CTCexp. 64.12 78.26 81.72 82.38 66.91
E/O 0.67 0.78 0.83 0.84 0.70
water samples, especially if synergistic, antagonistic or potentiating
effects between the components occur.
Our study focused on the cytotoxic and genotoxic effects of three
drugs, fromdifferent chemical classes (ciproﬂoxacin (CIP), aﬂuoroquin-
olone antibiotic; cyclophosphamide (CP), a neoplastic chlorinated
compound; tamoxifen (TAM), an estrogenic compound used as an anti-
cancer agent). Considering that these drugs can co-occur in water, the
toxic effects of mixtures (CIP + TAM and CTC) where compared to
their individual effects.
Toxicology has long been dominated by an emphasis on very high
doses and the assessment of toxic responses. In comparison with
human health risk assessment, ecological risk assessment is poorly un-
derstood. In the environment, it is important to know what happens
with a low dose, corresponding to real water contamination. The con-
centrations chosen were based on the range reported in the literature,
although the concentrations of PPCPs vary at each sitewith pharmaceu-
tical usage patterns, the size of the surrounding population, the speciﬁc
wastewater treatment available, and the discharge location. Thus, the
concentrations are not meant to be an exact match to what is found at
onemunicipalwastewater treatment plant, orﬁeld site, but to represent
concentrations that are environmentally reasonable. The high concen-
tration tested was near the highest reported concentrations found in
hospital wastewater up to 150 μg/L (Martins et al., 2008; Negreira
et al., 2013a, 2013b; Santos et al., 2013).
Table 3 summarized and compared the four bioassays.
In the range of doses tested (ng/L–10 μg/L), the dose–response of cell
viability observed after exposure of HepG2 cells to TAM, CIP and CP,
mainly after 72 h of exposure, exhibited a U-shape. This type of curve
was also observed when microalgae were exposed to CP. These kinds
of non-linear dose–response relationships are referred to hormetic re-
sponses and have been described across a wide range of organisms
(from bacteria to vertebrates), in response to exposure to at least 1000
different chemicals and environmental stressors. Hormesis is connected
with both acclimation and phenotypic plasticity, andmay play an impor-
tant role in allowing animals to adjust to changing environments
(Costantini et al., 2010). Deviations from linearity are favored by the oc-
currence of multiple concurrent and sequential events in toxicological
responses. Mechanisms contributing to hormetic responses at low
doses included overcompensation to a disruption in homeostasis;
adaptive responses based on inducible repair processes; interactions
among cell proliferation, cell-cycle delay, apoptosis, and DNA damage;
enhancement of gap junction intercellular communication at low doses
but inhibition at high doses; etc. (for a review see Hoffmann, 2009).
Hormesis is a biphasic dose–response that often results from the actions
of partial agonists and partial antagonists. TAM is an endocrine disruptor
due to its agonist and antagonist effect on estrogen receptor (Coezy et al.,
1982; Vandenberg et al., 2012). The low dose stimulating hormetic
responses could lead to undesirable effects e.g. proliferation of harmful
bacteria (Randall et al., 1947) or enhancement of proliferation of tumor
cells by antitumor drugs (Calabrese, 2005, 2013). In the case of chemo-
therapeutic agents, the low dose stimulation appears to reﬂect an adap-
tive response to tumor tissue. To address the interaction of binary
(CIP + TAM) or ternary mixtures (CIP + TAM + CP) the effects were
compared to the expected effects that were calculated from single
toxin toxicity obtained in the same experiments. The two reference
models of concentration addition (CA) and the independent action (IA)
were used to derive patterns of joint effects of mixture (Chou, 2006,
2011). The CA model assumes that mixed chemicals have the same
modeof action (MoA),whereas the IAmodel is based on the idea of a dis-
similar action of mixture components, usually to answer the question
whether the probability of toxicity from exposure to no chemical is inde-
pendent from the probability to another chemical (Altenburger et al.,
2003; Jonker et al., 2004, 2005).
Datamodeling allowed us to infer that all three toxins exerted inter-
active effects in HepG2 cell viability; bacteria viability (microtox®);
algae proliferation (algaltoxkit F™) and genotoxicity (comet assay). A
U-shape dose–response was observed for the cell viability test and
microtox® test with both kinds for the mixture. Both of these latter
tests reﬂect a mainly acute toxic effect. The application of the CA
model showed that the observed cytotoxic effects were lower than
expected, and an antagonistic pattern was identiﬁed.
Concerning the algaltoxkit F™ test and the comet assay, reﬂecting a
chronic toxic effect, both mixtures have a synergistic effect. While indi-
vidually, the three drugs would not be expected to cause DNA breaks or
inhibition of algae growth at these low doses, the drugs in the mixture
lead to a dose-dependent increase of effects. In general these effects
are more pronounced after a 72 h exposure compared to lower expo-
sure time conﬁrming a chronic effect, and an adaptive mechanism.
Fig. 4. Drug combination plot. Ratio expected (E)/observed (O) versus concentration. CIP + TAM ( ); CTC (x), at 24 h (A) and 72 h (B).
Fig. 5. Comparison of DNA breaks induced on HepG2 exposed to CIP (white), TAM (gray) or CP (black) during 24 h (A) to 72 h (B). The data are expressed as median value ± SD.
This is in line of the data obtained by Yusuf et al. (2000), even though
the doses used in their study were much higher.
The evidence suggests that if one measures biological effects too
early, the response may appear to ﬁt a threshold or linear model rather
than hormesis because insufﬁcient time has elapsed for the requisite
gene expression for an adaptive response. If one makes measurements
too late, the system may have already returned from the induced state
to the ground state.
Comparison between impact of both mixtures (CIP + TAM versus
CTC) shows that CP increased the antagonistic effect on cell viability and
bacteria bioluminescence; and the synergistic effect on DNA breaks for-
mation (comet assay). These data show clearly that the three drugs
have a differentmode of action. In the case of binarymixture TAM + CIP,
interaction could be due to the impact of TAM on membrane efﬂux. In-
deed, Darvari and Boroujerdi (2004) showed that tamoxifen biphasically
modulated the membrane efﬂux of doxorubicin (an antibiotic like CIP).
For all the three drugs the interaction could be due to interference on
biotransforming enzymes. Tamoxifen must be activated by the cyto-
chrome P450 system to exert its effects via anti-estrogenic metabolites
that are more potent than the parent compound (Coezy et al., 1982).
The main metabolites of tamoxifen are N-desmethyltamoxifen
(formed by CYP3A), and 4-hydroxytamoxifen and endoxifen (formed
byCYP2D6) (Desta et al., 2004). CP is not cytotoxic by itself but undergoes
activation through a metabolic step in vivo. Numerous metabolites
are known (Kerbusch et al., 2001) and the major ones are
chloroacetaldehyde, acrolein and 4-hydroxycyclophosphamide produced
by the mixed function of cytochrome P450 oxidase (CYP) present in he-
patic microsomes (Huang et al., 2000). The active metabolite (4-hydroxy
derivative) is produced mainly by CYP2B6. These metabolites are excret-
ed in the urine. N-dechloroethylation results in inactivation of anticancer
activity of CP and formation of the toxic byproduct chloroacetaldehyde.
This reaction is catalyzed by CYP3A4. Induction or inhibition of CYP
activity mediated by concomitantly administered drugs can change the
balance between the activating and inactivating metabolic pathways of
cyclophosphamide (Scripture et al., 2005). Ciproﬂoxacin is an inhibitor
of cytochrome P450 3A activity in vitro and in vivo (Xie et al., 2003). Cip-
roﬂoxacin inhibits the CYP which mediates CP biotransformation leading
to reduction in themetabolic ratio and a decrease in the levels of active 4-
OH-CP. The immunosuppressive effect of CP is hampered by ciproﬂoxa-
cin, which is detrimental to the treatment, explaining that treatment
did not anymore combine these two drugs. In the same way, TAM and
its metabolites N-desmethyltamoxifen and 4-hydroxytamoxifen inhibit
metabolism mediated by CYP 2B6, 2C9 and 2D6 (Sridar et al., 2002) but
increased CYP3A4 (Desai et al., 2002; Sane et al., 2008) and have the po-
tential to cause drug interactions (Scripture et al., 2005). Altogether,mod-
iﬁcations of the metabolic pathway lead in the enhancement of the
formation of genotoxic metabolites of CP such acrolein. The dG-acrolein
adduct has been reported to be considerablymoremutagenic inmamma-
lian cells than in Escherichia coli.Mammalian polymerase has been report-
ed to bypass the dG-acrolein lesion in the presence of proliferating cell
nuclear antigen (Kanuri et al., 2002).
To conﬁrm the link between DNA adduct formations and DNA
breaks (comet assay) experiments are underway in our laboratory,
DNA breaks can reﬂect two different events, either a direct attack of
DNA or the reparation of DNA damaged by a bulky adduct. In general
after repair cells will proliferate, whereas after DNAdamage and inaccu-
rate repair cells can die.
5. Conclusion
Only a battery-based approach, including in one hand biomarkers
and on other hand an acute and chronic aquatic toxic test on whole
organisms, investigating the causal relationship between exposures
and environmental pollutants will aid to assess water quality. Two
Fig. 6. Comparison of DNA breaks induced on HepG2 exposed to CIP + TAM (hatched) or CTC (stippling) during 24 h (A) to 72 h (B). The data are expressed as median value ± SD. The
numbers 1 to 5 refer to the mixture conditions explained in the M & M part (Table 1). Statistically signiﬁcant at p b 0.05 (*) and p b 0.01 (**) compared to control cell; @ signiﬁcant
difference between exposure to three drugs (CTC) compared to CIP + TAM.
Fig. 7.Growth inhibition of microalgae exposed 72 h to ciproﬂoxacin (CIP, white); tamox-
ifen (TAM, gray); and cyclophosphamide (CP, black). K2Cr2O7 corresponds to the positive
control. Results are expressed as median value ± SD of the percentage of viable algae
compared to control condition. Statistically signiﬁcant at p b 0.05 (*) compared to control
algae without any treatment.
Fig. 8. Comparison of microalgae growth inhibition induced by exposure to CIP + TAM
(hatched) or CTC (stippling) during 72 h. The data are expressed as median value ± SD.
The numbers 1 to 5 refer to the mixture conditions explained in the M &M part (Table 1).
endpoints (cell viability and microtox®) reﬂect the acute toxic effect
and give similar responses. The two other endpoints (DNA breaks and
algaltoxkit F™) reﬂect a chronic effect, and the adaptive response of
organisms.
The results of the mixture experiments demonstrate that chemicals
in real water samples act together in mixtures and how not only the
absolute concentrations of the mixture components are important but
also their contribution to the mixture effect. Throughout this study we
identiﬁed signiﬁcant hormetic responses with the cell viability tests
and algaltoxkit F™ test at low concentrations of drugs. The hormesis
phenomenon is characterized by low dose stimulation of the test
species over the control and high dose enhancement of adverse effects.
These data pinpoint the difﬁculties of risk assessment to low concentra-
tion (subnanograms) exposure and conﬁrm the data obtained by
Hernando et al. (2006) and Zegura et al. (2009). Consequently, while
individually these drugs would not be expected to cause acute toxicity
in environmental conditions, this study revealed that chronic endpoints
were a lotmore sensitive than acute endpoints, notably when the drugs
occurred simultaneously, and hence further research is needed to inves-
tigate chronic effects at environmentally relevant concentrations and in
mixtures. The synergism/antagonism observed in the present study
demonstrated the necessity to investigate the ecotoxicological effects
of contaminants at low concentration mixtures and at different time-
exposures.
Cell culture can offer several advantages over whole animal (or
organism) studies, e.g., reduced labor, sample volume, variability and
at least reduced cost.
Acknowledgment
This paper was prepared with ﬁnancial support by the French
National Research Agency, in the framework of the 2010 “CD2I” call
program, within the project “PANACEE” and by the French company.
The authors thank G.M. for English proofreading. The authors declare
that there are no conﬂicts of interests.
References
Altenburger R, Nendza M, Schüürmann G. Mixture toxicity and its modeling by quantita-
tive structure–activity relationships. Environ Toxicol Chem 2003;22:1900–15.
Barltrop JA, Owen TC, Cory AH, Cory JG. 5-(3-Carboxymethoxyphenyl)-2-(4,5-
dimethylthiazolyl)-3-(4-sulfophenyl)tetrazolium, inner salt (MTS) and related analogs
of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to
purple water-soluble formazans As cell-viability indicators. Bioorg Med Chem Lett
1991;1:611–4.
Baumgartner A, Cemeli E, Anderson D. The comet assay in male reproductive toxicology.
Cell Biol Toxicol 2007;25:81–98.
Besse J-P, Latour J-F, Garric J. Anticancer drugs in surface waters: what can we say about
the occurrence and environmental signiﬁcance of cytotoxic, cytostatic and endocrine
therapy drugs? Environ Int 2012;39:73–86.
Bound JP, Voulvoulis N. Predicted and measured concentrations for selected pharmaceu-
ticals in UK rivers: implications for risk assessment. Water Res 2006;40:2885–92.
Bouraoui S, Brahem A, Tabka F, Mrizek N, Saad A, Elghezal H. Assessment of chromosomal
aberrations, micronuclei and proliferation rate index in peripheral lymphocytes from
Tunisian nurses handling cytotoxic drugs. Environ Toxicol Pharmacol 2011;31:250–7.
Breithofer A, Graumann K, Scicchitano MS, Karathanasis SK, Butt TR, Jungbauer A. Regula-
tion of human estrogen receptor by phytoestrogens in yeast and human cells.
J Steroid Biochem Mol Biol 1998;67:421–9.
Fig. 9. Bioluminescence inhibition of bacteria exposed to ciproﬂoxacin (CIP, white); ta-
moxifen (TAM, gray); and cyclophosphamide (CP, black). Results are expressed asmedian
value ± SD of the percentage of inhibition compared to control condition. Statistically
signiﬁcant at p b 0.05 (*) compared to control algae without any treatment.
Fig. 10. Comparison of bioluminescence inhibition induced by exposure to CIP-TAM
(hatched) or CTC (stippling). The numbers 1 to 5 refer to themixture conditions explained
in theM&Mpart (Table 1). Results are expressed asmedian value ± SDof thepercentage
of viable bacteria compared to control (condition 0). Statistically signiﬁcant at p b 0.05 (*)
and p b 0.01 (**) compared to control; @ signiﬁcant difference between exposure to three
drugs (CTC) compared to CIP + TAM.
Table 3
Comparison of the four bioassays reﬂecting acute effect (cell or bacteria viability) or chronic effect (DNA damages or algae growth inhibition).
Bioassay Cell viability (MTS) DNA break (COMET) Algae growth inhibition
(algaltoxkit F™)
Bacteria activity (microtox®
CIP (alone) Hormesis/inhibition – – – (except inhibition wih high dose)
TAM (alone) Hormesis/inhibition – proliferation –
CP (alone) = (Inhibition high dose) – Hormesis (inhibition followed by proliferation) –
CIP + TAM Hormesis/antagonism + (synergy) inhibition Hormesis/synergy
CTC Hormesis/antagonism
(almost return to basal level)
++ (synergy) inhibition Hormesis/antagonism*
Comment Effects more pronounced
after 72 h exposure.
Effects less pronounced
after 72 h exposure.
Reﬂect repair system,
and chronic effect
Reﬂect chronic aquatic effect Inhibition of bacteria luminescence by CIP
could be explained by its antibiotic activity.
*Comparison between the two mixtures
condition shows an antagonist effect.
Reﬂect acute aquatic effect
CIP = ciproﬂoxacine; TAM = tamoxifen; CP = cyclophosphamid; CTC = mixture of CIP + TAM + CP.
Buerge IJ, Buser H-R, Poiger T, Müller MD. Occurrence and fate of the cytostatic drugs
cyclophosphamide and ifosfamide in wastewater and surface waters. Environ Sci
Technol 2006;40:7242–50.
Burgaz S, Karahalil B, Bayrak P, Taşkin L, Yavuzaslan F, Bökesoy I, et al. Urinary cyclophos-
phamide excretion and micronuclei frequencies in peripheral lymphocytes and in
exfoliated buccal epithelial cells of nurses handling antineoplastics. Mutat Res
1999;439:97–104.
Burgaz S, Karahalil B, Canhi Z, Terzioglu F, Ançel G, Anzion RBM, et al. Assessment of
genotoxic damage in nurses occupationally exposed to antineoplastics by the analysis
of chromosomal aberrations. Hum Exp Toxicol 2002;21:129–35.
Calabrese EJ. Cancer biology and hormesis: human tumor cell lines commonly display
hormetic (biphasic) dose responses. Crit Rev Toxicol 2005;35:463–582.
Calabrese EJ. Hormesis once marginalized, evidence now supports hormesis as the most
fundamental dose response. In: Mattson MP, Calabrese EJ, editors. Hormesis. Springer
science + Business Media; 2013. http://dx.doi.org/10.1007/978-1-60761-495-1_2.
Carabineiro SAC, Thavorn-Amornsri T, PereiraMFR, Figueiredo JL. Adsorption of ciproﬂox-
acin on surface-modiﬁed carbon materials. Water Res 2011;45:4583–91.
Catastini C, Mullot J-U, Boukari S, Mazellier P, Levi Y, Cervantes P, et al. Identiﬁcation de
molécules anticancéreuses dans les efﬂuents hospitaliers. Eur J Water Qual
2010;39:171–80.
Chou T-C. Theoretical basis, experimental design, and computerized simulation of
synergism and antagonism in drug combination studies. Pharmacol Rev
2006;58:621–81.
Chou T-C. The mass-action law based algorithm for cost-effective approach for cancer
drug discovery and development. Am J Cancer Res 2011;1:925.
Coe TS, Hamilton PB, Hodgson D, Paull GC, Stevens JR, Sumner K, et al. An environmental
estrogen alters reproductive hierarchies, disrupting sexual selection in group-spawning
ﬁsh. Environ Sci Technol 2008;42:5020–5.
Coezy E, Borgna J-L, Rochefort H. Tamoxifen and metabolites in MCF7 cells: correlation
between binding to estrogen receptor and inhibition of cell growth. Cancer Res
1982;42:317–23.
Costantini D, Metcalfe NB, Monaghan P. Ecological processes in a hormetic framework.
Ecol Lett 2010;13:1435–47.
Crane M, Watts C, Boucard T. Chronic aquatic environmental risks from exposure to
human pharmaceuticals. Sci Total Environ 2006;367:23–41.
Darvari R, Boroujerdi M. Concentration dependency of modulatory effect of amlodipine
on P-glycoprotein efﬂux activity of doxorubicin—a comparison with tamoxifen.
J Pharm Pharmacol 2004;56:985–91.
Desai PB, Nallani SC, Sane RS, Moore LB, Goodwin BJ, Buckley DJ, et al. Induction of
cytochrome P450 3A4 in primary human hepatocytes and activation of the human
pregnane X receptor by tamoxifen and 4-hydroxytamoxifen. Drug Metab Dispos
2002;30:608–12.
Desta Z, Ward BA, Soukhova NV, Flockhart DA. Comprehensive evaluation of tamoxifen
sequential biotransformation by the human cytochrome P450 system in vitro:
prominent roles for CYP3A and CYP2D6. J Pharmacol Exp Ther 2004;310:1062–75.
EFSA. Minimum criteria for the acceptance of in vivo alkaline comet assay reports. Efsa J
2012;10(11):2977–89.
Eguchi K, Nagase H, Ozawa M, Endoh YS, Goto K, Hirata K, et al. Evaluation of antimicro-
bial agents for veterinary use in the ecotoxicity test using microalgae. Chemosphere
2004;57:1733–8.
Emmanuel E, Perrodin Y, Keck G, Blanchard JM, Vermande P. Ecotoxicological risk assess-
ment of hospital wastewater: a proposed framework for raw efﬂuents discharging
into urban sewer network. J Hazard Mater 2005;117:1–11.
Frenzilli G, Nigro M, Lyons B. The comet assay for the evaluation of genotoxic impact in
aquatic environments. Mutat Res Rev Mutat Res 2009;681:80–92.
Fucic A, Jazbec A, Mijic A, Seso-Simic D, Tomek R. Cytogenetic consequences after occupa-
tional exposure to antineoplastic drugs. Mutat Res 1998;416:59–66.
Gartiser S, Brinker L, Erbe T, Kümmerer K, Willmund R. Contamination of hospital waste-
water with hazardous compounds as deﬁne § 7a. Acta Hydrochim Hydrobiol
1996;24:90–7.
Halling-Sørensen B, Nors Nielsen S, Lanzky PF, Ingerslev F, Holten Lützhøft HC, Jørgensen
SE. Occurrence, fate and effects of pharmaceutical substances in the environment—a
review. Chemosphere 1998;36:357–93.
Hartmann A, Alder AC, Koller T, Widmer RM. Identiﬁcation of ﬂuoroquinolone antibiotics
as the main source of umuC genotoxicity in native hospital wastewater. Environ
Toxicol Chem 1998;17:377–82.
Hernando MD, Heath E, Petrovic M, Barceló D. Trace-level determination of pharmaceuti-
cal residues by LC–MS/MS in natural and treated waters. A pilot-survey study. Anal
Bioanal Chem 2006;385:985–91.
Hoffmann GR. A perspective on the scientiﬁc, philosophical, and policy dimensions of
hormesis. Dose–response 2009;7:1–51.
Huang Z, Roy P, Waxman DJ. Role of human liver microsomal CYP3A4 and CYP2B6 in
catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide. Biochem
Pharmacol 2000;59:961–72.
Jean J, Perrodin Y, Pivot C, Trepo D, Perraud M, Droguet J, et al. Identiﬁcation and prioriti-
zation of bioaccumulable pharmaceutical substances discharged in hospital efﬂuents.
J Environ Manage 2012;103:113–21.
Johnson AC, Jürgens MD, Williams RJ, Kümmerer K, Kortenkamp A, Sumpter JP. Do
cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment
and human health? An overview and UK case study. J Hydrol 2008;348:167–75.
Jonker MJ, Piskiewicz AM, Castellà NII, Kammenga JE. Toxicity of binary mixtures of
cadmium–copper and carbendazim–copper to the nematode Caenorhabditis elegans.
Environ Toxicol Chem 2004;23:1529–37.
Jonker MJ, Svendsen C, Bedaux JJM, Bongers M, Kammenga JE. Signiﬁcance testing for
synergistic/antagonistic, dose level-dependent, or dose ration-dependent effects in
mixture dose–response analysis. Environ Toxicol Chem 2005;24(10):2701–13.
Jordan VC, Koerner S. Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen
receptor. Eur J Cancer 1975;11:205–6.
Kanuri M, Minko IG, Nechev LV, Harris TM, Harris CM, Lloyd RS. Error prone translesion
synthesis past gamma-hydroxypropano deoxyguanosine, the primary acrolein-derived
adduct in mammalian cells. J Biol Chem 2002;277:18257–65.
Karthikeyan KG, Meyer MT. Occurrence of antibiotics inwastewater treatment facilities in
Wisconsin, USA. Sci Total Environ 2006;361:196–207.
Kerbusch T, de Kraker J, Keizer HJ, van Putten JW, Groen HJ, Jansen RL, et al. Clinical phar-
macokinetics and pharmacodynamics of ifosfamide and its metabolites. Clin
Pharmacokinet 2001;40:41–62.
Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, et al. Pharmaceu-
ticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999–
2000: a national reconnaissance. Environ Sci Technol 2002;36:1202–11.
Kuemmerer K, Steger-Hartmann T, Meyer M. Biodegradability of the anti-tumour agent
ifosfamide and its occurrence in hospital efﬂuents and communal sewage. Water
Res 1997;31:2705–10.
Lindberg R, Jarnheimer P-A, Olsen B, JohanssonM, TysklindM. Determination of antibiotic
substances in hospital sewage water using solid phase extraction and liquid
chromatography/mass spectrometry and group analogue internal standards.
Chemosphere 2004;57:1479–88.
Lindberg RH, Wennberg P, Johansson MI, Tysklind M, Andersson BAV. Screening of
human antibiotic substances and determination of weekly mass ﬂows in ﬁve sewage
treatment plants in Sweden. Environ Sci Technol 2005;39:3421–9.
Liwei S, Jinmiao Z, Philip AS, ZijianW. Tamoxifen effects on the early life stages and repro-
duction of Japanese medaka (Oryzias latipes). Environ Toxicol Pharmacol 2007;24:
23–9.
Lu SC, Huang HY. Comparison of sulfur amino acid utilization for GSH synthesis between
HepG2 cells and cultured rat hepatocytes. Biochem Pharmacol 1994;47:859–69.
Ma J, Lu N, Qin W, Xu R, Wang Y, Chen X. Differential responses of eight cyanobacterial
and green algal species, to carbamate insecticides. Ecotoxicol Environ Saf 2006;63:
268–74.
Martins AF, Vasconcelos TG, Henriques DM, da S Frank C, König A, Kümmerer K. Concen-
tration of ciproﬂoxacin in Brazilian hospital efﬂuent and preliminary risk assessment:
a case study. CLEAN — Soil Air Water 2008;36:264–9.
McLellan RA, Drobitch RK, Monshouwer M, Renton KW. Fluoroquinolone antibiotics in-
hibit cytochrome P450-mediated microsomal drug metabolism in rat and human.
Drug Metab Dispos 1996;24:1134–8.
Mersch-Sundermann V, Knasmüller S, Wu X-J, Darroudi F, Kassie F. Use of a
human-derived liver cell line for the detection of cytoprotective, antigenotoxic and
cogenotoxic agents. Toxicology 2004;198:329–40.
Miao X-S, Bishay F, Chen M, Metcalfe CD. Occurrence of antimicrobials in the ﬁnal efﬂu-
ents of wastewater treatment plants in Canada. Environ Sci Technol 2004;38:
3533–41.
Negreira N, López de AldaM, Barceló D. On-line solid phase extraction–liquid chromatog-
raphy–tandemmass spectrometry for the determination of 17 cytostatics andmetab-
olites in waste, surface and ground water samples. J Chromatogr A 2013a;1280:
64–74.
Negreira N, Mastroianni N, López de Alda M, Barceló D. Multianalyte determination of 24
cytostatics and metabolites by liquid chromatography–electrospray–tandem mass
spectrometry and study of their stability and optimum storage conditions in aqueous
solution. Talanta 2013b;116:290–9.
Orias F, Perrodin Y. Characterisation of the ecotoxicity of hospital efﬂuents: a review. Sci
Total Environ 2013;454–455:250–76.
PhACT Database. Pharmaceutical Research and Manufacturers of America (PhRMA);
2006.
Randall WA, Price CW, Welch H. Demonstration of hormesis (increase in fatality rate) by
penicillin*. Am J Public Health Nations Health 1947;37:421–5.
Roberts PH, Thomas KV. The occurrence of selected pharmaceuticals in wastewater efﬂu-
ent and surface waters of the lower Tyne catchment. Sci Total Environ 2006;356:
143–53.
Rowney NC, Johnson AC, Williams RJ. Cytotoxic drugs in drinking water: a prediction and
risk assessment exercise for the Thames catchment in the United kingdom. Environ
Toxicol Chem 2009;28:2733–43.
Sane RS, Buckley DJ, Buckley AR, Nallani SC, Desai PB. Role of human pregnane X receptor
in tamoxifen- and 4-hydroxytamoxifen-mediated CYP3A4 induction in primary
human hepatocytes and LS174T cells. Drug Metab Dispos 2008;36:946–54.
Santos LHLML, Gros M, Rodriguez-Mozaz S, Delarue-Matos C, Penas A, Barcelo D, et al.
Contribution of hospital efﬂuents to the load of pharmaceuticals in urban wastewa-
ters: identiﬁcation of ecologically relevant pharmaceuticals. Sci Total Environ
2013;461–462:302–16.
Scripture CD, Sparreboom A, Figg WD. Modulation of cytochrome P450 activity: implica-
tions for cancer therapy. Lancet Oncol 2005;6:780–9.
Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low
levels of DNA damage in individual cells. Exp Cell Res 1988;175:184–91.
Sridar C, Kent UM, Notley LM, Gillam EM, Hollenberg PF. Effect of tamoxifen on the enzy-
matic activity of human cytochrome CYP2B6. J Pharmacol Exp Ther 2002;301:
945–52.
Thomas KV, Hilton MJ. The occurrence of selected human pharmaceutical compounds in
UK estuaries. Mar Pollut Bull 2004;49:436–44.
Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, et al. Single cell
gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ
Mol Mutagen 2000;35:206–21.
Tjan-Heijnen VC, Postmus PE, Ardizzoni A, Manegold CH, Burghouts J, van Meerbeeck J,
et al. Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of
ciproﬂoxacin and roxithromycin in small-cell lung cancer patients: an EORTC
double-blind placebo-controlled phase III study. Ann Oncol 2001;12:1359–68.
Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs Jr DR, Lee D-H, et al. Hormones
and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose re-
sponses. Endocr Rev 2012;33:378–455.
Verlicchi P, Al Aukidy M, Galletti A, Petrovic M, Barceló D. Hospital efﬂuent: investigation
of the concentrations and distribution of pharmaceuticals and environmental risk as-
sessment. Sci Total Environ 2012;430:109–18.
Wenzel SDA, Schäfers C, Vollmer G, Michna H, Diel P, Köln DS, et al. Research efforts to-
wards the development and validation of a test method for the identiﬁcation of endo-
crine disrupting chemicals. Contract 2001;6:000015.
Xie H-J, Griskevicius L, Broberg U, Lundgren S, Carlens S, Meurling L, et al. Alteration of
pharmacokinetics of cyclophosphamide and suppression of the cytochrome P450
genes by ciproﬂoxacin. Bone Marrow Transplant 2003;31:197–203.
Yusuf AT, Vian L, Sabatier R, Cano JP. In vitro detection of indirect-acting genotoxins in the
comet assay using HeP G2 cells. Mutat Res 2000;468:227–34.
Zegura B, Heath E, Cernosa A, Filipic M. Combination of in vitro bioassays for the determi-
nation of cytotoxic and genotoxic potential of wastewater, surface water and drink-
ing water samples. Chemosphere 2009;75:1453–60.
Zorita S, Mårtensson L, Mathiasson L. Occurrence and removal of pharmaceuticals in a
municipal sewage treatment system in the south of Sweden. Sci Total Environ
2009;407:2760–70.
Zounkova R, Kovalova L, Blaha L, Dott W. Ecotoxicity and genotoxicity assessment of cy-
totoxic antineoplastic drugs and their metabolites. Chemosphere 2010;81:253–60.
Zuccato E, Castiglioni S, Fanelli R. Identiﬁcation of the pharmaceuticals for human use
contaminating the Italian aquatic environment. J Hazard Mater 2005;122:205–9.
